QUEBEC, Dec. 19, 2025 /CNW/ - Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) ...

QUEBEC, Dec. 19, 2025 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the "Company") ...

• Company continues preclinical studies for Thykamine™ in MASH and Fibrosis, furthering the understanding of Thykamine™'s mechanism of action.
• Thykamine™: A New Player in the Field of Anti-Inflammatory ...
  ]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update-15355317Fri, 12 Dec 2025 14:45:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update-15355316
  • Company continues preclinical studies for Thykamine™ in MASH and Fibrosis, furthering the understanding of Thykamine™'s mechanism of action.
  • Thykamine™: A New Player in the Field of Anti-Inflammatory ...
    ]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update-15355316Thu, 04 Dec 2025 14:45:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-announces-publication-of-landmark-study-highlighting-thykamine-as-a-promising-new-anti-inflammatory-agent-15335422

    QUÉBEC, Dec. 4, 2025 /CNW/ - Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXV: GSD) (OTCQB: DVHGF), ...

    ]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-announces-publication-of-landmark-study-highlighting-thykamine-as-a-promising-new-anti-inflammatory-agent-15335422Thu, 04 Dec 2025 14:45:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-announces-publication-of-landmark-study-highlighting-thykamine-as-a-promising-new-anti-inflammatory-agent-15335423

    QUÉBEC, Dec. 4, 2025 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXV: GSD) (OTCQB: ...

    ]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-announces-publication-of-landmark-study-highlighting-thykamine-as-a-promising-new-anti-inflammatory-agent-15335423Wed, 26 Nov 2025 18:01:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-its-fourth-quarter-and-annual-2025-financial-results-and-appointment-of-a-new-board-member-15315945
    • Fourth quarter distribution revenues of $1.3 million
    • Fourth quarter net loss of $0.4 million, $0.003per ...
      ]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-its-fourth-quarter-and-annual-2025-financial-results-and-appointment-of-a-new-board-member-15315945Wed, 26 Nov 2025 18:01:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-its-fourth-quarter-and-annual-2025-financial-results-and-appointment-of-a-new-board-member-15315943
      • Fourth quarter distribution revenues of $1.3 million
      • Fourth quarter net loss of $0.4 million, $0.003per ...
        ]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-its-fourth-quarter-and-annual-2025-financial-results-and-appointment-of-a-new-board-member-15315943